Sutro Biopharma ($STRO) Insider Trading & Smart Money Activity

Sutro Biopharma, Inc. · Biotechnology · Latest filing Jun 11, 2026

Sutro Biopharma, Inc. ($STRO) has 2 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
2

STRO insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All STRO insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Truist Securities Raises to buy PT $50 +11.9%+5.1% Read
Analyst Truist Securities Raises to buy PT $50 +11.9%+5.1% Read

1W / 1M / 6M = how STRO moved from the trade or filing date.

Analyst ratings on STRO

DateFirmActionRatingPrice target1W1M6MStory
Truist Securities Raises buy $50 +11.9%+5.1% Read
Truist Securities Raises buy $50 +11.9%+5.1% Read

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions